REGISTER OF INTERESTS

SIGN Guideline 116: Management of Diabetes (Type 2 Diabetes Subgroup)
Published March 2010
27 November 2013
Financial
Specific
CHAIR
John R Petrie, Reader in Diabetic
Medicine / Honorary Consultant
Physician / Professor of Diabetic
Medicine

Reader,
Diabetic
Medicine
(University of
Dundee)
Professor of
Diabetic
Medicine
(University of
Glasgow)
GSK (advisory
board, lecture
fee)
Takeda
(conference
accommodation
and travel –
EASD Vienna)

Non-Specific
Shareholder in
Lecht Ski
Company Ltd

Non-financial
Specific
None

Non-personal

Last updated

Research Grant
(Wyeth
Pharmaceuticals)

28/04/2011

Non-Specific
Trustee of
Novo-Nordisk
Research
Foundation

Daiichi Sankyo
(endpoint
committee
coordinator)

Research Grant
(Lifescan
Scotland)

Pfizer (advisory
board)
BMS Pharma
(advisory board)
Red Hot Irons
(lecture fee)

Novo-Nordisk
(advisory board)
GUIDELINE DEVELOPMENT GROUP MEMBER
Greg Jones, Consultant Physician
None

Advisory boards
for GSK, Novo
Nordisk, Takeda,
and Sarroli Aventi

None

1

None

None

12/05/2008

REGISTER OF INTERESTS SIGN Guideline 116: Management of Diabetes (Type 2 Diabetes Subgroup) Published March 2010 27 November 2013 Financial Specific None Non-financial Specific None Non-personal Last updated Non-Specific None Non-Specific None None 05/04/2011 Joan McDowell. Consultant Physician in Diabetes / Endocrinology Speakers fees from various meetings (EliLilly. Senior Lecturer in Clinical Pharmacology None None None None None 26/04/2011 2 . Senior Lecturer None None None None None 22/05/2008 David McGrane. BMS) Liz McIntyre. Astra Zeneca) Guest of company for international meetings (GSK. GSK) None None None Grant to Diabetes Endowment Fund at Monklands from Novo-Nordisk 04/06/2008 Mary Joan McLeod. Aventis. Clinical Senior Lecturer 26/04/2011 Lectures (BMS. Specialist Registrar Consultant Physician and Diabetologist (NHS GGC) Consultancy (BMS) Simon Maxwell.

Glaxo Smith Kline) 09/02/2010 Ailsa Power. Novo) None Scottish representative for Primary Care Diabetes Society (charity) None None Sarah Wild.REGISTER OF INTERESTS SIGN Guideline 116: Management of Diabetes (Type 2 Diabetes Subgroup) Published March 2010 27 November 2013 Ewan Pearson. Senior Lecturer / Clinician Scientist Financial Specific None Non-Specific None Non-financial Specific None Non-Specific None Non-personal Last updated Payment to university account for speakers fees / attendance / registration (Novo Nordisk. Novartis. General Practitioner Advisory board work (MSD. Assistant Director of Pharmacy Assistant Director (NHS Education for Scotland) None None None None Richard Quigley. Bristol Myers Squibb / Astra Zeneca. Lilly. Senior Lecturer in Epidemiology & Public Health None None None None None 3 05/01/2009 . GSK.